Form 4: Illumina SVP, Chief Information Officer Carissa Rollins Reports Changes in Beneficial Ownership
SEC Form 4
Carissa Rollins, SVP and Chief Information Officer of Illumina, reports acquisition and disposal of common stock and performance shares.
Summary
- On March 5, 2025, Carissa Rollins, SVP, Chief Information Officer of Illumina, reported changes in beneficial ownership.
- Rollins acquired 7,283 shares of common stock and disposed of an unspecified amount.
- Following the reported transactions, Rollins beneficially owns 18,560 shares of common stock.
- Rollins was also granted 8,496 performance shares tied to the company's three-year average operating margin for fiscal years 2025-2027, vesting on January 2, 2028.
- An additional 8,496 performance shares were granted, linked to the company's relative total shareholder return for the fiscal year ending January 2, 2028.
- The vesting of restricted stock units is scheduled in four equal installments on February 15 of 2026, 2027, 2028, and 2029, contingent upon continued service.
- The balance includes 192 shares acquired through the Employee Stock Purchase Plan.
Sentiment
Score: 6
Explanation: The document is a standard regulatory filing, indicating routine executive compensation adjustments. The sentiment is neutral, reflecting standard business practice.
Positives
- The grant of restricted stock units and performance shares to a key executive like the Chief Information Officer can be seen as a positive incentive for performance and retention.
Risks
- The value of the performance shares is contingent on the company's performance, specifically the three-year average operating margin and relative total shareholder return, introducing uncertainty.
Future Outlook
The number of performance shares issued will depend on Illumina's three-year average operating margin for fiscal years 2025-2027 and the company's relative total shareholder return for the fiscal year ending January 2, 2028.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies like Illumina. It provides transparency into the alignment of executive incentives with company performance.
Comparison to Industry Standards
- Executive compensation packages including stock options, restricted stock units, and performance shares are standard practice among publicly traded companies, particularly in the technology and biotechnology sectors.
- Companies like Thermo Fisher Scientific, Danaher, and Agilent Technologies also utilize similar compensation structures to incentivize their executives.
- The vesting schedules and performance metrics used by Illumina are likely benchmarked against industry peers to ensure competitiveness in attracting and retaining top talent.
Stakeholder Impact
- The changes in beneficial ownership may have a minor impact on shareholders, as they reflect the executive's stake in the company.
- Employees may be indirectly affected by the performance-based incentives, as they align executive goals with overall company success.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction |
| 02/15/2026 | First vesting date for 25% of restricted stock units |
| 02/15/2027 | Second vesting date for 25% of restricted stock units |
| 01/02/2028 | Vesting date for performance shares based on three-year average operating margin and relative total shareholder return |
| 02/15/2028 | Third vesting date for 25% of restricted stock units |
| 02/15/2029 | Final vesting date for 25% of restricted stock units |
| 03/07/2025 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.